Daily concurrent preoperative chemoradiotherapy using new superselective intra-arterial infusion via superficial temporal artery for oral cancer

DOI Web Site 7 Citations 6 References
  • Yamamoto Noriyuki
    Department of Oral and Maxillofacial Surgery, Nagoya University Graduate School of Medicine
  • Tohnai Iwai
    Department of Oral and Maxillofacial Surgery, Yokohama City University Graduate School of Medicine
  • Mitsudo Kenji
    Department of Oral and Maxillofacial Surgery, Nagoya University Graduate School of Medicine
  • Nishiguchi Hiroaki
    Department of Oral and Maxillofacial Surgery, Nagoya University Graduate School of Medicine
  • Saito Masaki
    Department of Oral and Maxillofacial Surgery, Nagoya University Graduate School of Medicine
  • Nakashima Hideyuki
    Department of Oral and Maxillofacial Surgery, Nagoya University Graduate School of Medicine
  • Sugimura Tomotaka
    Department of Oral and Maxillofacial Surgery, Nagoya University Graduate School of Medicine
  • Furue Hiroki
    Department of Oral and Maxillofacial Surgery, Nagoya University Graduate School of Medicine
  • Fukui Takafumi
    Department of Oral and Maxillofacial Surgery, Yokohama City University Graduate School of Medicine
  • Ueda Minoru
    Department of Oral and Maxillofacial Surgery, Nagoya University Graduate School of Medicine

Bibliographic Information

Other Title
  • 口腔癌に対する浅側頭動脈よりの超選択的動注法（HFT法）を用いた連日同時放射線化学療法
  • ―頸部リンパ節転移の検討―
  • —Cervical lymph node metastasis—

Abstract

Seventeen oral cancer patients with cervical lymph node metastasis were treated by preoperative chemoradiotherapy using superselective intra-arterial infusion via the superficial temporal artery. Radiotherapy (total dose: 40Gy/4 weeks) and superselective intra-arterial infusion chemotherapy using DOC (total dose: 60mg/m2, 15mg/m2/week) and CDDP (total dose: 100mg/m2, 5mg/m2/day) were performed, followed by surgery. The pathological effects of resected lymph node metastasis after surgery were grade III, IV (Oboshi-Shimosato classification) in level I, II. This method is a promising strategy for oral cancer with cervical lymph node metastasis.

Journal

  • Toukeibu Gan

    Toukeibu Gan 33 (1), 6-10, 2007

    Japan Society for Head and Neck Cancer

Citations (7)*help

See more

References(6)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top